Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions
Authors:
- 8 May 2024
- journal article
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 111 (6) , 1061-1083
Abstract
No abstract availableKeywords
Funding Information
- UT Health San Antonio
- Cedars-Sinai Medical Center
- National Institutes of Health
- National Cancer Institute (R01CA211575, R01CA207456, R01CA204954, R21CA220078, R01CA211707, R00CA256519, U19C8804/A7058)
This publication has 92 references indexed in Scilit:
- MYC as a target for cancer treatmentCancer Treatment Reviews, 2021
- Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding SitesThe American Journal of Human Genetics, 2020
- Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human CancersThe American Journal of Human Genetics, 2019
- Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian womenGynecologic Oncology, 2019
- Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin DisordersJournal of Investigative Dermatology, 2019
- Characterization of ovarian cancer cell lines as in vivo models for preclinical studiesGynecologic Oncology, 2016
- Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common DiseasesThe American Journal of Human Genetics, 2014
- Super-Enhancers in the Control of Cell Identity and DiseaseCell, 2013
- Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutationsLaboratory Investigation, 2012
- Histone modifications at human enhancers reflect global cell-type-specific gene expressionNature, 2009